Recently, F0 embryonic stem (ES) cell mice have been produced by injection of ES cells into eight-cell embryos using either laser-or piezo-assisted injection systems. To simplify the injection procedure, we have optimized the conventional blastocyst injection method, free of laser-or piezo-assisted micromanipulation systems, to produce F0 ES cell pups. To increase the efficiency of producing mice from ES cell injection into eight-cell and blastocyst stage embryos, we have tested: 1) the effect of activating ES cell before injection, 2) the effect of in vitro culture in medium optimized for the survival of both ES cells and embryos, and 3) the effect of transferring the micromanipulated embryos into the oviduct versus into the uterus of CD1 foster mice. Two B6D2 hybrid ES cell lines were used for injection in a multifactorial analysis to evaluate the efficiency of producing live chimeric and F0 ES cell mice. Our results demonstrate that the activation of ES cells and the appropriate culture conditions are crucial parameters influencing the generation of F0 ES cell offspring. Transfer of blastocysts injected with ES cells into the oviduct of 0.5-day postcoitum pseudopregnant females increased the number of live animals with higher chimera proportion. Under these conditions, injections into eight-cell embryos produce a high number of F0 ES mice, and the conventional blastocyst injection method produces a lower number of F0 ES cell pups; however, the efficiency of production of chimeric mice with germline transmission was high. We have developed an economical and efficient technique for producing fully ES cell-derived F0 mice with full germline transmission that can be applied in many laboratories without the use of piezo or laser instruments.
INTRODUCTION
During the last fifteen years, the conventional system for producing fully embryonic stem (ES) cell-derived mice was the tetraploid complementation approach [1, 2] . This method generates ES cell gene-targeted mice directly, because the tetraploid embryo only contributes to placental development, but its efficiency is low, it fails to yield viable mice when ES cells from inbred strains are used, and pups produced by this method often suffer from congenital abnormalities and exhibit poor viability [3, 4] . Recently, two methods based on the injection of ES cells into four-or eight-cell embryos using either laser-assisted [5] or piezo-assisted [6] injection systems have been developed. Both methods have produced F0 ES cell pups with full germline transmission, and are easier and more efficient than the tetraploid complementation method. These methods are based on previous observations that the eight-cell embryo injection method produced elevated numbers of viable germline chimeras [7, 8] . As judged by the extent of ES cellderived coat color, the eight-cell embryo injections resulted in higher ES cell contribution than the blastocyst injections [5] [6] [7] . On the other hand, both methods require expensive equipment and extensive experience, and demand more time than the conventional system, which may influence the quality of the micromanipulated embryos. Furthermore, the piezo micromanipulator usually uses mercury, which can produce toxicity problems [9, 10] .
Despite the advances during recent years on gene targeting technologies using ES cells [11] [12] [13] , there are some factors that have never been analyzed that could increase the efficiency of producing F0-generation mice. One of these factors is the activation (to synchronize the ES cell in the log phase of growth) of the ES cells before injecting them into the embryo. Another factor that may increase the efficiency of producing ES cell mice is the use of an appropriate culture medium optimized to allow the survival of both ES cells and embryos. It has been suggested that inappropriate culture media may lead to death of some ES cells, which could result in a leak of their cytoplasm and, thereby, poisoning of the host embryo [6] . Lastly, the site of embryo transfer may also have an impact on efficiency. Usually, micromanipulated blastocysts are transferred into the uterus of 2.5-day postcoitum (dpc) pseudopregnant females, but blastocysts can also be transferred into the oviduct of a 0.5-dpc pseudopregnant female, which allows them to stay in the oviduct until the uterotubal junction is opened.
The first objective of our work was to simplify and reduce the cost of the injection procedure to produce F0 ES cell mice using the conventional injection system, free of laser or piezo equipment. The second aim of our work was to increase the efficiency of producing ES cell mice using ES cell injection (without laser or piezo equipment) into eight-cell and into blastocyst stage embryos. To accomplish this aim, we have analyzed: 1) the effect of ES cell activation before injection, 2) the effect of the in vitro culture after injection using an appropriate culture medium optimized for the survival of both ES cells and embryos, and 3) the effect of the site of transfer of the micromanipulated embryos (into the oviduct versus the uterus of CD1 pseudopregnant mice). Exploring these variables, we intended to develop a method for the efficient production of F0 ES cell mice that can be easily applied in many laboratories to generate genetically manipulated mice.
MATERIALS AND METHODS

Embryo Donor, Recipient Mice, and Embryo Transfer
Mice were kept on a 14L:10D light cycle. CD1 female mice (8-10 wk old) were superovulated by intraperitoneal injections of 7.5 IU of equine chorionic gonadotropin (eCG; Intervet, Boxmeer, Holland), followed 48 h later by 5 IU of human CG (hCG; Lepori, Farma-Lepori, Barcelona, Spain). On the same day as hCG injection, female mice were paired with male mice of the same strain to allow mating. Eight-cell embryos and blastocysts were collected 2.5 and 3.5 days post coitum (dpc), respectively. After ES cell injection, eight-cell-and blastocyst-injected embryos were cultured over 24 h in groups of 20-25 in a 40-ll droplet of potassium simplex optimization medium (KSOM) supplemented with amino acids overlaid with mineral oil in a humidified atmosphere of 5% CO 2 at 378C. After culture, blastocysts and compacted morulae were transferred into the left uterus of a 2.5-dpc pseudopregnant CD1 female [14] or into the left oviduct of a 0.5 dpc pseudopregnant CD1 female [15] . To generate chimeras and F0 ES-derived mice, pregnancies were allowed to develop to term.
All chemicals and media were purchased from Sigma Chemical Co. (Madrid, Spain) unless otherwise stated. All animal experiments were performed in accordance with the Internal Institutional Animal Care and Use Committee of Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (Madrid, Spain).
ES Cell Lines, ES Transgenic Lines, and Culture
Two ES cell lines were derived in our laboratory from fertilized embryos of (C57BL/6 3 DBA/2) hybrid female mice by previously described methods [16] . ES cell lines were initially checked for pluripotency based on the expression of molecular markers specific for ES cells [17] , and the ability to successfully produce chimeras with germline transmission. Karyotype analysis was realized as previously described [18] . Both cell lines were XY.
Production of the transgenic ES cells carrying a 4.5-kb fragment of the mouse telomerase reverse transcriptase promoter (Tert) located upstream from the first ATG of the Tert gene open reading frame, and ligated to EGFP (Clontech Laboratories, Inc., Palo Alto, CA) to promote the expression of EGFP, has been previously reported [16] . ES cell transformation is also described in the same publication [16] , and transgenic integration was confirmed by EGFP PCR [19] . Undifferentiated mouse ES cells were maintained on mitomycin-C-treated mouse embryonic fibroblast cells on 0.1% gelatin-coated tissue plates in ES cell medium: Dulbecco modified Eagle medium plus 4500 mg/L glucose, glutaMAX, and pyruvate (Invitrogen, Carlsbad, CA) supplemented with 20% Defined Fetal Bovine Serum Gold (PAA Laboratories, Cölbe, Germany), 2 mM glutamine, 1 mM minimum essential medium nonessential amino acids solution, 1 mM b-mercaptoethanol, 1000 U/ml leukemia inhibitory factor, and an antibiotic mixture containing 100 U/ml penicillin and 100 lg/ml streptomycin.
Generation of F0 ES Cell Mice
Undifferentiated ES cell colonies were selected and briefly trypsinized to obtain individual cells. Ten cells were injected into eight-cell embryos, and twelve cells were injected into blastocysts. The injection of mouse ES cells into mouse blastocysts was carried out as previously described [18] . The injection into eight-cell embryos was performed using a micromanipulator setup identical to that used for blastocysts injection [18] . A standard injection needle was used to introduce the ES cells (Fig. 1, A and B) . Injected embryos were cultured overnight in KSOM þ amino acids and surviving blastocysts were transferred to surrogate females the day after injection (0.5 or 2.5 dpc).
EGFP cells, embryos, and fetuses were visualized at 488 nm excitation wavelength with an inverted fluorescence microscope (Eclipse TE 2000; Nikon, Kznagawa, Japan), or with a Leica TCS SP5 confocal laser scanning unit attached to an inverted epifluorescence microscope (DMI6000; Leica, Newcastle, UK), with an HCX PL APO 633/1.40-0.6 oil objective. Images were acquired and processed with accompanying Leica confocal software.
Experimental Design
To increase the efficiency for producing F0 ES cell mice using ES cell injection into eight-cell and blastocyst-stage embryos, we analyzed three factors in at least four replicates: 1) Effect of ES cell activation before injection. ES cell activation was induced to synchronize the ES cells in the log phase of growth before injecting them into the embryo. To do this, medium was changed to allow ES cells to grow in fresh ES medium for 2 h before injection. Culture produces a reduction of serum and growth factor that may reduce metabolism in the ES cells (metabolic depletion using serum or growth factor starvation is a technique commonly employed to G0-synchronize eukaryotic cells); by culturing the cells in a fresh medium prior to injection, we expected to activate the metabolism of the growth synchrony ES cells. We can not be sure that only activated cells were injected, but considering that the fresh media activate the metabolism of the ES cells, we expect that the majority of the cells were synchronous. In the same experimental replication, a group of embryos was injected with activated ES cells, while, for the remaining embryos, nonactivated cells were used.
Because we found a positive effect with the ES cell activation, in the rest of the experiment (2 and 3), all the ES cells used were previously activated.
2) Effect of in vitro culture of injected embryos using appropriate culture medium optimized for survival of both ES cells and embryos. In the same experimental replication embryos were cultured in KSOM or ES cell media, or in KSOM supplemented with 4% ES cell medium for 24 h.
3) Effect of the site of the micromanipulated embryo transfer. In the same experimental replication, the manipulated embryos were randomly allocated to either the left oviduct or the left uterus of different females.
To analyze the influence of these factors on the efficiency of F0 ES cell mouse generation, we followed the fate of ES cells expressing EGFP under the telomerase promoter [16] that was injected into eight-cell or blastocyst-stage embryos. Fluorescent images of embryos after ES cell injection allowed us to quantify, under the different factors that we analyzed, the amount of inner cell mass (ICM) cells that were derived from the EGFP-transgenic ES cells and the survival of ES cells during the in vitro culture of the manipulated embryos. 
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The effect of these factors on the efficiency of the generation of F0 ES cell mice was also quantified by analyzing the percentage of ES cell coat contribution and the germline transmission. As has been previously reported, complete ES cell coat contribution and 100% germline transmission were indicative of less than 0.1% of host contribution [5] . Pups produced by injection of ES cells into embryos were categorized as: host-derived; chimera; chimeras with more than 75% ES cell coat color; and F0 ES cell mice.
Statistical Analysis
Data were analyzed using the SigmaStat software package (Jandel Scientific, San Rafael, CA). Cleavage rate and embryo development were analyzed using ANOVA with arcsine transformation. Data (percentages) were analyzed by z-test. Significant differences within the column were defined as P , 0.05.
RESULTS
Effect of Activation of ES Cells Before Their Injection into Eight-Cell or Blastocyst-Stage Recipient Embryos by Conventional Micro-Needle to Generate F0 ES Cell Mice
All the experiments were carried out with two ES cell lines (B6D2F1) by injection into eight-cell or blastocyst embryos. Because no differences were found between the cell lines, the results of both lines were grouped. As we can see in Table 1 , activation of the ES cells before injection is a crucial step to increasing the generation of F0 ES cell mice in both cases, in either the eight-cell embryo injection or the blastocyst injection method. Based on the visualization of the coat color in the newborns, ES cell activation increases the average number of pups directly produced from ES cells after injection in both eight-cell embryos and blastocysts (Fig. 1, C and F) . All the mice analyzed with 100% ES cell coat color (n ¼ 11) produced germline transmission. In addition, all the animals with more than 75% ES cell coat color were males.
ES cell activation also increased the percentage of mice with more than 75% ES cell coat color after injection in both eightcell injected embryos and blastocysts (Table 1) . No differences were found in percentages of germline transmission between chimeras produced with activated or nonactivated ES cells; however, germline transmission was higher in chimeric mice with more than 75% ES cell coat color produced by eight-cell embryo injection than in those produced by blastocyst injection (86% versus 71%, respectively). Activation of the ES cells did not affect the number of newborns. Using our method with activated B6D2F1 ES cells and without laser or piezo equipment (Fig. 1, A and B) , we have obtained similar results to those of previous reports [5, 6] , which used different genetic backgrounds of ES cells injected into eight-cell embryos, and better results than those published using blastocyst injection [5] .
Fluorescent images of blastocysts resulting from injection of activated or nonactivated ES cells (Tert-EGFP) into eight-cell embryos (24 and 48 h after injection) suggested that ES cell activation was crucial to increasing the number of ICMs that were derived entirely from the EGFP cells (Fig. 1, D 
and E).
We found similar results when we observed the fluorescent images of blastocysts resulting from injection of activated or nonactivated ES cells into blastocyst embryos (24 h after injection; data not shown).
Effect of the Culture In Vitro Using an Appropriated Culture Medium to Allow the Survival of Both ES Cells and Embryos to Generate F0 ES Cell Mice
In a preliminary experiment, we analyzed the effect of different concentrations of ES medium added to KSOM in the amount of one-cell embryos that developed to blastocyst stage (data not shown). We found that supplementation of KSOM with ES media in a proportion higher than 10% reduces blastocyst yield, whereas, when ES media constituted less than 10%, no detrimental effect on blastocyst yield was observed. For this reason, we decided to supplement KSOM with 4% of ES medium in the rest of the experiments (this is the concentration that we routinely use in our protocol to produce ES cell chimeras by aggregation with eight-cell-stage embryos). First, we used the fluorescent image of the eight-cell or blastocyst embryos injected with the Tert-EGFP ES cells to (Fig. 2A) ; however, when culture was performed in KSOM without ES medium, we observed a reduction in the number of ES cells, and only in a small proportion of the embryos did the injected ES cells form the cells that will contribute to the ICM lineage (Fig. 2B) . When the embryos were cultured in KSOM during 48 h, a smaller population of EGFP fluorescent cells was observed, indicating that 48 h of culture in KSOM affected the viability of the injected ES cells. After blastocyst injection, no effect of culture media was observed after 24 h of culture.
As we can see in Table 2 , the medium used for injected eight-cell embryo culture had no effect in the number of newborns, but affected the number of chimeras with more than 75% of ES cells and with 100% of ES cell coat color contribution. Regarding injection into blastocysts, no differences were observed between the culture in KSOM þ ES or in ES media for the number of chimeras with more than 75% of ES cell coat color, and for the production of F0 ES cell mice (Table 2 ). Culture in KSOM had a negative effect on both parameters ( Table 2) .
Effect of Embryo Transfer into the Oviduct Versus into the Uterus to Generate F0 ES Cell Mice
In a preliminary experiment, we transferred blastocysts into the oviduct of 0.5-dpc females and recovered the embryos 1, 2, and 3 days after the transfer. We found that the blastocysts remained in the oviduct until the uterotubal junction was opened at 3.5 dpc, then the embryos were implanted in the uterus. During the 2.5 days when the blastocysts remained in the oviduct, they performed one cell division and then went into diapause until they passed to the uterus. At that time, the embryos had double the number of cells than the Day-3.5 blastocysts (Fig. 3A) (number of cells at blastocyst stage, 48.8 6 6 [n ¼ 15]; number of cells of blastocysts after 2.5 days of diapause, 96.4 6 9 [n ¼ 14]). Using fluorescent ES cells (Tert-EGFP), we found that injected embryos that were transferred into the oviduct of a 0.5-dpc female had an increased proportion of fluorescent cells during diapause, indicating that these cells divided more efficiently than the blastomeres of the host embryos.
At 24 h after ES cell injection into eight-cell embryos and into blastocysts, a group of embryos were transferred into the 
FIG. 3. A)
Embryos recovered from the oviduct 2.5 days after the transfer of the embryos at blastocyst stage into a 0.5-dpc female. B) The same embryos seen in A after 2 h of in vitro culture in KSOM showing an increase in volume. Bar ¼ 20 lm. C) Fetuses and placentas recovered from a female 13 days after blastocyst transfer: on the left, the five biggest fetuses were produced from blastocysts transferred into the uterus of a 2.5-dpc female; on the right, the five smallest fetuses were produced from blastocyst transfer into the oviduct of a 0.5-dpc female. Differences in growth were originated by the implantation delay of the embryos transferred into the oviduct. Bar ¼ 4 mm.
FACTORS AFFECTING CHIMERA PRODUCTION oviduct of 0.5-dpc pseudopregnant females, and the rest of the embryos into the uterus of 2.5-dpc pseudopregnant females. At 13 days after embryo transfer, fetuses were recovered. The weight of the fetuses was significantly different (P , 0.01) (418 6 34 mg and 224 6 13 mg between those derived from embryos transferred into the uterus and those transferred into the oviduct, respectively [Fig. 3C]) . The weight of the placentas was not different (104 6 16 mg and 92 6 9 mg for fetuses derived from embryos transferred into the uterus and into the oviduct, respectively [ Fig. 3C]) ; however, those placentas attached to fetuses derived from embryos transferred into the uterus were more developed and showed more blood irrigation than those placentas of embryos transferred into the oviduct. Length of the pregnancy was also different: gestation length when blastocysts were transferred into the oviduct was 1.5-2 days longer.
After blastocysts injection, the number of newborns was not altered as a result of the site of the embryo transfer (Table 3) ; nevertheless, when we transferred eight-cell-injected embryos into the uterus, the number of newborns was significantly higher than when they were transferred into the oviduct. In the eight-cell embryo injection group, the percentage of chimeras and the percentage of F0 ES cell mice produced were not altered by the site of the embryo transfer; however, there was a tendency to produce more F0 ES cell mice when embryos were transferred into the uterus. When blastocysts were injected, the embryo transfer into the oviduct increased the number of chimeras and the percentage of chimeras with more than 75% ES cell coat color contribution (Table 3) .
DISCUSSION
Mutant mice are habitually generated by injection of genetically modified ES cells into blastocyst-stage host embryos, resulting in F0 generation chimeric mice partially derived from the ES cells [20] . Only if ES cells contribute to the germ line will the chimera produce F1-generation mice heterozygous for the transgenic ES cells. In terms of speed-up phenotype of mutant mice, the tetraploid approach was a major advance over the blastocyst method [1, 3] , because the resulting F0 generation mice are almost entirely ES cellderived. However, the tetraploid approach is an inefficient process for producing live mice. Tokunaga and Tsunoda [7] showed that injection of hybrid ES cells into eight-cell embryos resulted in greater ES cell coat color contribution and germline transmission compared with conventional blastocyst injection. Saburi et al. [8] demonstrated that single ES cells injected into eight-cell embryos could generate chimeras. Based on these observations, two new methods have been reported to generate F0 embryonic stem (ES) cell mice by injection of ES cells into eight-cell embryos using either a laser-assisted [5] or a piezoassisted [6] injection system. The aim of our study was to develop a method, free of the laser-or piezo-assisted injection system, for the efficient production of F0 ES cell mice that can be easily applicable in the majority of the transgenic mouse laboratories. In our work, we have used a combination of ES cells (B6D2F1) and host embryos (outbred CD1) that have been traditionally proven to be more challenging using the classical blastocyst injection method. Nevertheless, the use of these breeds has some advantages, such as good response to superovulation, good in vitro culture (IVC) embryo quality, and good maternal instinct of CD1 females. Different genetic backgrounds have previously been used in the laser-and piezoassisted methods; however, we believe that the factors analyzed in this work should be useful for the majority of combinations of ES cells and host embryos, regardless of the method used to penetrate the zona pellucida.
It has been generally accepted that the mammalian embryo starts its development with all cells identical, and the first differences between cells emerge only when the inside (cells that will contribute to the ICM lineage) and outside (cells that will contribute to the trophectoderm lineage) cells are formed at morulae stage [21] . For this reason, it has been reported that the different efficiency between blastocyst injection versus eightcell injection is that, at blastocyst stage, the ICM is already formed, and, as a result, the injected ES cells must integrate within the already formed ICM and compete with these cells to give rise to the proper embryo [6] . At eight-cell stage, the injection of ES cells before ICM formation might provide a competitive advantage to the injected ES cells, which are already committed to the ICM, over the endogenous, undifferentiated blastomeres. However, recent findings have shown that cells in the mouse embryo can differ in their developmental fate and potency as early as the four-cell stage [21, 22] . Our results indicate that, at this early eight-cell stage, even if at the four-cell stage each blastomere has a determined cell fate, the embryo has the plasticity to accept the injected ES cells as precursor for the ICM lineage. However, at the blastocyst stage, the blastomeres have lost this plasticity, and the ES cells must compete with the already existing blastomeres that form the ICM. According to our results, activation of the ES cells will allow them to form a major proportion of the ICM. Using blastocyst injection, we have found that ES cell activation produces mice that are largely ES cell derived, and, in some cases, completely derived (Table 1) . This is in disagreement with previous work [5] , in which it was shown that no male F0 was produced with 100% ES cell coat color contribution using blastocyst injections. This difference may be due to the activation of the ES cells, which might provide a competitive advantage to the injected, activated ES cells over the endogenous blastomeres of the ICM.
Poueymirou et al. [5] also suggested that the eight-cell method could lead to a greater contribution to the developing embryos via an ''all or none'' phenomenon: either the ES cells contributed substantially to the ICM, thus resulting in complete coat color contribution and no chimeras, or the mice were entirely host derived. We disagree with the ''all or none'' phenomenon, because we have found a similar proportion of males with 100% and with more than 75% ES cell coat color contribution. We think that, after the injection of ES cells into the eight-cell embryos, ES cells have an advantage over the existing blastomeres in the formation of the ICM lineage, and the rest of the embryo will form the trophectoderm; however, in some cases, in addition to the injected ES cells, some of the embryonic blastomeres acquire the properties to form the ICM. The differences between our work and Poueymirou's work could have arisen from the combination of ES cells and host embryos used; in fact, Poueymirou et al. [5] also found male chimeras when they used Swiss Webster as host embryo strain, which is a strain very close to CD1. In previous studies, it has been suggested that culture medium may be important to the survival of ES cells injected in the embryo. Huang et al. [6] suggested that culture media may produce damage in the injected ES cells that might leak their cytoplasm and affect the viability of the embryos. Our results demonstrate that, after ES cell injection into eight-cell embryos, the production efficiency of chimeric mice was increased when the embryos were cultured in a medium optimized for survival of both ES cells and embryos. Moreover, in ES cell-injected blastocyst embryos, the culture in ES or KSOM þ ES media is crucial to increasing the efficiency of chimera production. This is probably due to a positive effect of ES medium upon the survival of the ES cells injected into the blastocysts. In connection with our results, somatic cell nuclear transfer (SCNT) embryos are usually cultured in embryonic media of simple salt composition, based on the common belief that they have to assume the biological patterns of a normal embryo. However, it has been reported that MEMa-a culture medium commonly used for somatic cells-allows high rates of preimplantation development and development to term of mouse SCNT embryos [23, 24] .
Embryo transfer is a crucial step in completing the procedures of transgenic animal production. In mice, the window of implantation is under strict regulation by ovarian hormones [25] . It is accepted that asynchronously transferred blastocysts into the oviduct are held in abeyance until the uterus reaches a state of receptivity, late on Day 3-3.5 of pregnancy [26] , then oviduct-transferred embryos of different ages implant in the uterus at the same time [27] . Our results agree with these reports; blastocysts that were transferred into the oviduct of a 0.5-dpc female stayed in the oviduct for 3 days, until the communication between oviduct and uterus was opened and the uterus was receptive. Moreover, asynchronously transferred blastocysts into oviduct of a 0.5-dpc female, or synchronously transferred into the uterus of a 2.5-dpc female, resulted in differences in weight of fetuses recovered 13 days after the embryo transfer, indicating that blastocysts transferred into the oviduct implant later than embryos transferred into the uterus. In agreement with previous work [28] , we have found that the implantation delay increases blastocyst cell number and allows them to develop beyond the hatching blastocyst stage. However, these embryos went into diapause in the hatched blastocyst stage. The implantation delay is also manifested at the end of the pregnancy, resulting in a 1.5-to 2-day increase in the mean length of pregnancy. This implantation delay may have some effect on the viability of ES cell-injected embryos and/or in the percentage of chimeras and F0 ES cell mice produced. The dormancy may differentially affect the embryo and the ES cells that have been injected. Our results show that, for the blastocysts injected with ES cells, implantation delay did not have any effect on the numbers of newborns; however, implantation delay increases the percentage of chimeras, and the percentage of males born with more than 75% of ES cell coat color. This suggests that injected ES cells may have some advantage over the endogenous blastomeres of the ICM during the dormancy of the embryo. In agreement with this hypothesis, when 24-h IVC eight-cell-injected embryos were transferred into the oviduct, the number of newborns was reduced in comparison with the number of newborns obtained when the embryos were transferred into the uterus. In this case, the advantage of the injected ES cells over the embryo during the implantation delay may produce a reduction in the number of viable embryos, because the major part of the ICM is already formed by the injected ES cells.
We have demonstrated that eight-cell embryo injection free of laser or piezo equipment is an efficient method for producing healthy and full germline-competent mice from hybrid ES cells. Blastocyst injection of ES cells may also produce F0 ES cell mice, but the method is less efficient, and demands more time than the eight-cell injection method. One of the most crucial factors for the efficiency of the method is the activation of the ES cells before injection. Based on our results, it is strongly recommended that this activation be performed before the ES cells are injected either into eight-cell or blastocyst-stage embryos. In addition, based on our results, we strongly recommend the use of appropriated culture media for manipulated eight-cell embryos and the subsequent transfer of the manipulated embryos into the uterus when eight-cell embryos are injected, and into the oviduct when blastocysts are injected. Finally, the use of a fluorescent marker to follow the survival and integration of the ES cell after injection would be a good tool to test the developmental potency of new pluripotent stem cell lines, new transformed ES cell lines, new combinations of ES cells and host embryo strains, or to select those embryos the ICM of which is derived from the ES cells at the blastocyst stage.
